rs200945035
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM1BP4_Moderate
The NM_000295.5(SERPINA1):c.1075A>G(p.Lys359Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,613,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K359M) has been classified as Benign.
Frequency
Consequence
NM_000295.5 missense
Scores
Clinical Significance
Conservation
Publications
- alpha 1-antitrypsin deficiencyInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
- hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- cystic fibrosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SERPINA1 | NM_000295.5 | c.1075A>G | p.Lys359Glu | missense_variant | Exon 5 of 5 | ENST00000393087.9 | NP_000286.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000922 AC: 14AN: 151862Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000139 AC: 35AN: 251256 AF XY: 0.000169 show subpopulations
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461860Hom.: 0 Cov.: 33 AF XY: 0.0000344 AC XY: 25AN XY: 727230 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000921 AC: 14AN: 151980Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74270 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Alpha-1-antitrypsin deficiency Uncertain:5
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
- -
This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 359 of the SERPINA1 protein (p.Lys359Glu). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with SERPINA1-related conditions. This variant is also known as p.Lys335Glu or PI*ETokyo. ClinVar contains an entry for this variant (Variation ID: 556005). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SERPINA1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at